Your browser doesn't support javascript.
loading
T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma.
Bezverbnaya, Ksenia; Hammill, Joanne A; Cummings, Derek; Bojovic, Bojana; Groisman, Bella; Baker, Christopher L; Aarts, Craig; Hayes, Danielle L; Rill, Donna; Xu, Stacey X; Bader, Andreas G; Helsen, Christopher W; Bramson, Jonathan L.
Afiliación
  • Bezverbnaya K; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada.
  • Hammill JA; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Center for Discovery in Cancer Research, McMaster University, Hamilton, Canada.
  • Cummings D; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Center for Discovery in Cancer Research, McMaster University, Hamilton, Canada.
  • Bojovic B; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Center for Discovery in Cancer Research, McMaster University, Hamilton, Canada.
  • Groisman B; McMaster Immunology Research Center, McMaster University, Hamilton, Canada.
  • Baker CL; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Center for Discovery in Cancer Research, McMaster University, Hamilton, Canada.
  • Aarts C; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Center for Discovery in Cancer Research, McMaster University, Hamilton, Canada.
  • Hayes DL; Triumvira Immunologics, Hamilton, Canada.
  • Rill D; Triumvira Immunologics, Hamilton, Canada.
  • Xu SX; Triumvira Immunologics, Hamilton, Canada.
  • Bader AG; Triumvira Immunologics, Hamilton, Canada.
  • Helsen CW; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Triumvira Immunologics, Hamilton, Canada.
  • Bramson JL; McMaster Immunology Research Center, McMaster University, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada; Center for Discovery in Cancer Research, McMaster University, Hamilton, Canada; Office of the Vice Dean, Research, Faculty of Health Sciences, McMaster Universit
Cytotherapy ; 25(5): 490-501, 2023 05.
Article en En | MEDLINE | ID: mdl-36781360
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido